Non-Current Assets
Indefinite-Lived Research and Development Assets
Gilead Sciences Indefinite-Lived Research and Development Assets remained flat by 0.0% to $2.3B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.4%, from $2.89B to $2.3B. Over 2 years (FY 2023 to FY 2025), Indefinite-Lived Research and Development Assets shows a downward trend with a -43.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2015
Last reportedQ1 2026May 7, 2026
Metric ID:
indefinite_lived_rd_assetsHistorical Data
10 periods
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.07B | $4.64B | $4.64B | $2.89B | $2.89B | $2.89B | $2.7B | $2.7B | $2.3B | $2.3B |
| QoQ Change | — | -34.4% | +0.0% | -37.7% | +0.0% | +0.0% | -6.6% | +0.0% | -14.8% | +0.0% |
| YoY Change | — | — | — | — | -59.1% | -37.7% | -41.8% | -6.6% | -20.4% | -20.4% |
Range$2.3B – $7.07B
CAGR-39.3%
Avg YoY Growth-31.0%
Median YoY Growth-29.1%
Indefinite-Lived Research and Development Assets at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's indefinite-lived research and development assets?
- Gilead Sciences (GILD) reported indefinite-lived research and development assets of $2.3B in Q1 2026.
- How has Gilead Sciences's indefinite-lived research and development assets changed year-over-year?
- Gilead Sciences's indefinite-lived research and development assets decreased by 20.4% year-over-year, from $2.89B to $2.3B.
- What is the long-term trend for Gilead Sciences's indefinite-lived research and development assets?
- Over 2 years (2023 to 2025), Gilead Sciences's indefinite-lived research and development assets has grown at a -43.0% compound annual growth rate (CAGR), from $7.07B to $2.3B.